George Matcham
Förmögenhet: 275 844 $ per 2026-09-30
Förmögenhet: 275 844 $ per 2026-09-30
George Matcham is currently an Independent Director at Instil Bio, Inc. since 2018.
Formerly, Dr. Matcham was a Non-Executive Director at Chimeric Therapeutics Ltd. (Australia) from 2021 to 2023.
From 2017 to 2018, Dr. Matcham was SVP-CAR T CMC & Technology Development at Celgene Corp.
Dr. Matcham also served as Chief Operating Officer at Celgene Cellular Therapeutics.
Education includes graduate studies at the University of Cambridge and undergraduate and doctorate degrees from the University of Cardiff.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
INSTIL BIO, INC. 0,56 % | 2026-06-11 | 38 100 ( 0,56 % ) | 275 844 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| INSTIL BIO, INC. | Direktör/Styrelseledamot | 2018-09-01 |
| Företag | Position | Slut |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Direktör/Styrelseledamot | 2023-08-03 |
| CELGENE | Företagsledare/Principal | 2018-06-01 |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Verksamhetschef | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Health Technology |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Chimeric Therapeutics Ltd. (Australia)
Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån